UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Cox Capital Mgt LLC

Cox Capital Mgt LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 24.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,570 shares of the healthcare conglomerate’s stock after purchasing an additional 1,478 shares during the quarter. UnitedHealth Group comprises about 2.6% of Cox Capital Mgt LLC’s portfolio, making the stock its 6th biggest position. Cox Capital Mgt LLC’s holdings in UnitedHealth Group were worth $3,985,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also modified their holdings of the company. Keebeck Wealth Management LLC boosted its stake in UnitedHealth Group by 11.6% in the second quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock valued at $5,185,000 after acquiring an additional 1,122 shares during the last quarter. Ascension Capital Advisors Inc. bought a new position in UnitedHealth Group in the third quarter valued at approximately $216,000. Physician Wealth Advisors Inc. bought a new position in UnitedHealth Group in the third quarter valued at approximately $207,000. Bartlett & Co. LLC boosted its stake in UnitedHealth Group by 5.7% in the third quarter. Bartlett & Co. LLC now owns 164,353 shares of the healthcare conglomerate’s stock valued at $82,865,000 after acquiring an additional 8,873 shares during the last quarter. Finally, Great Valley Advisor Group Inc. raised its holdings in UnitedHealth Group by 5.8% in the third quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock worth $17,292,000 after purchasing an additional 1,884 shares during the period. 85.69% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the topic of several analyst reports. Piper Sandler cut their target price on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a report on Wednesday, January 17th. Royal Bank of Canada reiterated an “outperform” rating and issued a $596.00 target price on shares of UnitedHealth Group in a report on Thursday, February 29th. Stephens reiterated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a report on Thursday, February 8th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Friday, January 19th. Finally, Bank of America restated a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a report on Thursday, March 7th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $579.33.

UnitedHealth Group Stock Performance

Shares of UNH stock traded down $1.68 during midday trading on Friday, hitting $490.01. 2,846,975 shares of the company were exchanged, compared to its average volume of 4,168,188. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The firm has a market capitalization of $451.75 billion, a P/E ratio of 20.60, a PEG ratio of 1.35 and a beta of 0.54. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $554.70. The firm’s 50 day moving average price is $505.61 and its two-hundred day moving average price is $518.05.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The firm had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.34 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.79 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 31.54%.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.